| scholarly article | Q13442814 |
| P50 | author | Richard Lathe | Q50637138 |
| Robert G. Will | Q118106031 | ||
| P2093 | author name string | J Collinge | |
| O Windl | |||
| T A Campbell | |||
| R de Silva | |||
| A Springbett | |||
| K C Sidle | |||
| M S Palmer | |||
| M Dempster | |||
| T Esmonde | |||
| J P Estibeiro | |||
| P433 | issue | 3 | |
| P921 | main subject | United Kingdom | Q145 |
| Creutzfeldt-Jakob disease | Q49989 | ||
| P304 | page(s) | 259-264 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Human Genetics | Q5937167 |
| P1476 | title | Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene | |
| P478 | volume | 98 |
| Q98245634 | A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis |
| Q33259107 | A major genetic component of BSE susceptibility |
| Q47671996 | Agrypnia excitata in a patient with progeroid short stature and pigmented Nevi (Mulvihill-Smith syndrome). |
| Q48706231 | Alpha1 antichymotrypsin signal peptide polymorphism in sporadic Creutzfeldt-Jakob disease |
| Q27007967 | An overview of human prion diseases |
| Q44131875 | Analysis of the prion protein in primates reveals a new polymorphism in codon 226 (Y226F). |
| Q34389352 | Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease |
| Q48557029 | Ancestral origins of the prion protein gene D178N mutation in the Basque Country |
| Q35211717 | Approaches to identify genes for complex human diseases: lessons from Mendelian disorders |
| Q37523094 | Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases |
| Q43822973 | Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). |
| Q34171325 | Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain |
| Q45094135 | Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. |
| Q60921189 | Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene |
| Q57092926 | Creutzfeldt-Jakob disease cluster in an Australian rural city |
| Q32153658 | Creutzfeldt-Jakob disease segregating in a three generation Danish family |
| Q92248516 | Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation |
| Q44296790 | Creutzfeldt-Jakob disease: clinical features, epidemiology and tests |
| Q40855107 | Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. |
| Q33754628 | Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study |
| Q57274061 | Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid |
| Q91604185 | Estimating relative CWD susceptibility and disease progression in farmed white-tailed deer with rare PRNP alleles |
| Q33911183 | Evaluation of PRNP expression based on genotypes and alleles of two indel loci in the medulla oblongata of Japanese Black and Japanese Brown cattle |
| Q33334421 | Evidence for a pathogenic role of different mutations at codon 188 of PRNP |
| Q37280507 | Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy |
| Q48411819 | Evidence for zoonotic potential of ovine scrapie prions. |
| Q56830857 | Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK |
| Q41604182 | Familial Creutzfeldt-Jakob disease with a novel 120-bp insertion in the prion protein gene |
| Q35122319 | Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. |
| Q35539781 | Heterologous aggregates promote de novo prion appearance via more than one mechanism. |
| Q37567829 | Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology |
| Q48721370 | Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients |
| Q41831450 | Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion |
| Q38445787 | Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance |
| Q73365367 | Increased risk of stroke in patients with the A12308G polymorphism in mitochondria |
| Q24651920 | Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice |
| Q37024622 | Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases. |
| Q44886629 | Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. |
| Q47690532 | Methods for Molecular Diagnosis of Human Prion Disease |
| Q34403513 | Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. |
| Q35549016 | Molecular and clinical classification of human prion disease |
| Q44451927 | Molecular classification of sporadic Creutzfeldt-Jakob disease. |
| Q35488760 | Molecular neurology of prion disease |
| Q34462913 | Molecular pathology of human prion disease |
| Q37462236 | Molecular pathology of human prion diseases |
| Q33604074 | New variant Creutzfeldt-Jakob disease |
| Q35105917 | Pathologic evidence that the T188R mutation in PRNP is associated with prion disease |
| Q28210578 | Polymorphism at codon 174 of the prion-like protein gene is not associated with sporadic Alzheimer's disease |
| Q38099068 | Prion disease: a tale of folds and strains |
| Q47139941 | Prion diseases are undercompulsory notification in Brazil: Surveillance of cases evaluated by biochemicaland/or genetic markers from 2005 to 2007. |
| Q26741258 | Prion diseases: immunotargets and therapy |
| Q73692926 | Prion protein binds copper within the physiological concentration range |
| Q81251224 | Prion protein immunohistochemistry in Creutzfeldt-Jakob disease |
| Q37949697 | Prion protein self-interaction in prion disease therapy approaches. |
| Q35531568 | Proteinase K-resistant material in ARR/VRQ sheep brain affected with classical scrapie is composed mainly of VRQ prion protein. |
| Q36968647 | Review. The origin of the prion agent of kuru: molecular and biological strain typing. |
| Q34474868 | Review: contribution of transgenic models to understanding human prion disease. |
| Q77154138 | Scrapie |
| Q36523240 | Sensitivity of protein misfolding cyclic amplification versus immunohistochemistry in ante-mortem detection of chronic wasting disease |
| Q34693238 | Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice |
| Q37353880 | Small-molecule theranostic probes: a promising future in neurodegenerative diseases. |
| Q35007270 | Susceptibility of European red deer (Cervus elaphus elaphus) to alimentary challenge with bovine spongiform encephalopathy |
| Q35913122 | The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients |
| Q35815746 | The Features of Genetic Prion Diseases Based on Chinese Surveillance Program |
| Q46911435 | The M129V polymorphism of codon 129 in the prion gene (PRNP) in the Danish population |
| Q85180476 | The Prion Diseases |
| Q79564001 | The configuration of the Cu2+ binding region in full-length human prion protein |
| Q38507000 | The influence of PRNP polymorphisms on human prion disease susceptibility: an update. |
| Q37327437 | The late 1970s: a lull in the action on kuru |
| Q24522314 | The molecular biology of prion propagation. |
| Q46464219 | The presence of valine at residue 129 in human prion protein accelerates amyloid formation. |
| Q48313878 | The prion diseases: Creutzfeldt-Jakob, Gerstmann-Sträussler-Scheinker, and related disorders |
| Q28288758 | The state of the prion |
| Q34542865 | The transmission dynamics of BSE and vCJD. |
| Q41570752 | Transgenic animals as models of neurodegenerative diseases in humans |
| Q34289917 | Transmissible spongiform encephalopathies. |
| Q34613223 | Understanding the natural variability of prion diseases |
| Q84127203 | Variably protease-sensitive prionopathy: a novel disease of the prion protein |
| Q33706965 | Variant Creutzfeldt-Jakob disease. |
| Q33956087 | Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health |
Search more.